CR20150030A - ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES - Google Patents

ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES

Info

Publication number
CR20150030A
CR20150030A CR20150030A CR20150030A CR20150030A CR 20150030 A CR20150030 A CR 20150030A CR 20150030 A CR20150030 A CR 20150030A CR 20150030 A CR20150030 A CR 20150030A CR 20150030 A CR20150030 A CR 20150030A
Authority
CR
Costa Rica
Prior art keywords
dual action
dual
action receiver
fixing proteins
antigen fixing
Prior art date
Application number
CR20150030A
Other languages
Spanish (es)
Inventor
Huiquan Han
Xiaolan Zhou
Qing Chen
Mei-Mei Tsai
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to CR20150030A priority Critical patent/CR20150030A/en
Publication of CR20150030A publication Critical patent/CR20150030A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Esta descripción se refiere a proteínas fijadoras de antígeno del receptor de acción dual antagonista, por ejemplo anticuerpos y método para utilizar el anticuerpo de receptor de acción dual para el tratamiento de enfermedades patológicas. El anticuerpo del receptor de acción dual puede comprender un anticuerpo para receptores ActRII y también puede utilizarse para tratar una condición patológica. Las condiciones patológicas pueden comprender enfermedades de desgaste muscular o cualquier enfermedad que requiera la estimulación del crecimiento muscular.This description relates to antagonist dual action receptor antigen binding proteins, for example antibodies and method for using the dual action receptor antibody for the treatment of pathological diseases. The dual-action receptor antibody can comprise an antibody to ActRII receptors and can also be used to treat a pathological condition. Pathological conditions may include diseases of muscle wasting or any disease that requires stimulation of muscle growth.

CR20150030A 2015-01-23 2015-01-23 ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES CR20150030A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20150030A CR20150030A (en) 2015-01-23 2015-01-23 ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20150030A CR20150030A (en) 2015-01-23 2015-01-23 ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES

Publications (1)

Publication Number Publication Date
CR20150030A true CR20150030A (en) 2016-04-07

Family

ID=56103156

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150030A CR20150030A (en) 2015-01-23 2015-01-23 ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES

Country Status (1)

Country Link
CR (1) CR20150030A (en)

Similar Documents

Publication Publication Date Title
CO7240399A2 (en) Dual-acting receptor antagonist antigen binding proteins and their uses
ECSP17063327A (en) ANTIDLL3 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
CY1124787T1 (en) ANTI-GITR ANTIBODIES AND METHODS OF USING THEM
UY36942A (en) ANTIGEN UNION PROTEINS THAT ACTIVATE THE LEPTINE RECEIVER
CR20190071A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
CL2017001217A1 (en) Antibody drug conjugates.
BR112017013176A2 (en) chimeric antigen receptors and methods for using them
CO2018014010A2 (en) Alpha-synuclein antibodies and uses thereof
CL2019000799A1 (en) Antibodies and fragments thereof that bind to the human cannabinoid 1 (cb1) receptor. (divisional application 201602433)
ECSP16089579A (en) PROTEINS AGONISTS OF SINGLE CHAIN TRAIL RECEPTORS.
ECSP10010322A (en) ANTIBODIES AGAINST THE INFLUENZA VIRUS AND METHODS OF USE OF THE SAME
PE20161210A1 (en) ANTI-MCAM ANTIBODIES AND ASSOCIATED METHODS OF USE
MX2019008722A (en) Glucagon receptor binding proteins and methods of use thereof.
MX2022002056A (en) Compounds for the treatment of bovine or swine respiratory disease.
NI202000051A (en) MONOCLONAL ANTIBODIES AND METHODS FOR USING THE SAME.
BR112017024852A2 (en) Double nk-1 / nk-3 receptor antagonists for the treatment of sex hormone dependent diseases
CO2020000260A2 (en) Chimeric antibodies for the treatment of amyloid deposition diseases
CR20190086A (en) Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6
EA201792312A1 (en) CONSTRUCTIONS BASED ON KALIHEAMICIN AND METHODS OF THEIR APPLICATION
BR112019011461A2 (en) improved nk-based cell therapy
BR112018072697A2 (en) composition, and method for treating a disease in a subject
CR20150030A (en) ANTIGEN FIXING PROTEINS ANTAGONISTS OF THE DUAL ACTION RECEIVER AND ITS USES
EA201692564A1 (en) COMBINED THERAPY
EA202190504A1 (en) METHODS FOR TREATMENT OF PSORIASIS
AR115992A2 (en) ANTIGEN BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR